AbCellera Biologics Inc. (ABCL) Social Stream



AbCellera Biologics Inc. (ABCL): $8.64

-0.44 (-4.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ABCL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

AbCellera Biologics Inc (ABCL) Price Targets From Analysts

Use the tables below to see what analysts covering AbCellera Biologics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-07 5 $45 $25 $33 $9.08 263.44%
2021-11-09 4 $55 $25 $45.25 $9.08 398.35%
2021-11-09 4 $53 $25 $42.75 $9.08 370.81%
2021-11-09 5 $53 $25 $42.75 $9.08 370.81%
2021-12-05 5 $53 $25 $40.8 $9.08 349.34%
2021-12-05 6 $53 $25 $40.8 $9.08 349.34%
2021-12-19 7 $53 $25 $39.833 $9.08 338.69%
2021-12-21 7 $53 $25 $38 $9.08 318.5%
2021-12-21 7 $45 $25 $33 $9.08 263.44%

The Trend in the Analyst Price Target


Over the past 40 weeks, ABCL's average price target has gone down $19.4.

ABCL reports an average of 123.64% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 2 55 25 47.20 15.61 202.37%
2021-11-09 5 53 25 42.75 14.71 190.62%
2021-08-28 2 55 25 45.40 17.58 158.25%
2021-11-09 5 55 25 45.25 14.71 207.61%
2021-11-09 4 53 25 42.75 14.71 190.62%

ABCL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ABCL has a higher upside potential (average analyst target price relative to current price) than 844.62% of all US stocks.
  • AbCellera Biologics Inc's variance in analysts' estimates is lower than -644.51% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, AbCellera Biologics Inc's number of analysts covering the stock is higher than 95.24% of them.
  • ABCL has a higher average analyst price target than 186.33% of stocks in the large market cap category.

In the Pharmaceutical Products industry, VIR, VCEL, and TIL are the three stocks most similar to AbCellera Biologics Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ABCL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5573 seconds.